G2086 Off base opioid tx 70min

Office-based treatment for opioid use disorder, including development of the treatment plan, care coordination, individual therapy and group therapy and counseling; at least 70 minutes in the first calendar month

Medically Unlikely Edits (effective October 1, 2026)

Medicare pricing for G2086

Physician Fee Schedule (CY 2026, RVU26D)

Status A: active, paid separately under the PFS if covered. National amounts: non-facility $491.33, facility $362.73 (total RVUs 14.71 / 10.86 × $33.4009 conversion factor). Work RVU 8.36, practice expense RVU 5.73 non-facility and 1.88 facility, malpractice RVU 0.62. Global period XXX. Qualifying APM participants are paid at a $33.5675 conversion factor.

Payer policies and prior authorization for G2086

Payer coverage policies that name G2086

G2086 appears in 1 coverage policy from Aetna.

PayerPolicyRole in policyReviewedDocument
AetnaExtended-Release Buprenorphine Injectables (0910)listed, no stanceDec 30, 2025payer document

Medicaid fee-for-service

Prior authorization required or conditional in IN.

  • LA: $376.21 (professional), effective Jul 1, 2025
  • MS: $313.74 (comprehensive), effective Jul 1, 2026
  • ND: $0.00 (physician), effective Aug 1, 2026
  • VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
  • WY: $78.50 (outpatient_hospital_apc, Ambulatory Surgical Centers), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.